Invesco Ltd. Tarsus Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 682,097 shares of TARS stock, worth $35.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

682,097

Previous 391,563 74.2%

Holding current value

$35.3 Million

Previous $10.6 Million 110.81%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.54 - $34.6 $6.26 Million - $10.1 Million	290,534 Added 74.2%	682,097 $22.4 Million
Q2 2024 Aug 13, 2024	BUY	$25.17 - $38.73 $4.23 Million - $6.51 Million	167,994 Added 75.14%	391,563 $10.6 Million
Q1 2024 May 14, 2024	BUY	$19.61 - $39.22 $2.46 Million - $4.93 Million	125,696 Added 128.43%	223,569 $8.13 Million
Q4 2023 Feb 12, 2024	BUY	$12.98 - $20.73 $1.27 Million - $2.03 Million	97,873 New	97,873 $1.98 Million
Q2 2023 Aug 11, 2023	SELL	$11.57 - $19.63 $224,562 - $380,998	-19,409 Reduced 31.73%	41,769 $754,000
Q1 2023 May 12, 2023	BUY	$11.92 - $16.27 $52,972 - $72,303	4,444 Added 7.83%	61,178 $769,000
Q4 2022 Feb 13, 2023	BUY	$14.12 - $18.72 $226,922 - $300,849	16,071 Added 39.52%	56,734 $831,000
Q3 2022 Nov 14, 2022	SELL	$14.08 - $18.5 $27,512 - $36,149	-1,954 Reduced 4.59%	40,663 $696,000
Q2 2022 Aug 15, 2022	BUY	$11.08 - $19.08 $162,155 - $279,235	14,635 Added 52.3%	42,617 $622,000
Q1 2022 May 16, 2022	BUY	$14.49 - $24.28 $59,090 - $99,013	4,078 Added 17.06%	27,982 $471,000
Q4 2021 Feb 14, 2022	SELL	$21.21 - $29.68 $99,899 - $139,792	-4,710 Reduced 16.46%	23,904 $538,000
Q3 2021 Nov 15, 2021	SELL	$21.45 - $29.22 $38,910 - $53,005	-1,814 Reduced 5.96%	28,614 $616,000
Q2 2021 Aug 17, 2021	BUY	$27.16 - $38.59 $31,750 - $45,111	1,169 Added 4.0%	30,428 $882,000
Q1 2021 May 17, 2021	BUY	$27.37 - $47.25 $270,744 - $467,397	9,892 Added 51.08%	29,259 $943,000
Q4 2020 Feb 16, 2021	BUY	$19.17 - $49.62 $371,265 - $960,990	19,367 New	19,367 $801,000

Others Institutions Holding TARS

# of Institutions

170

Shares Held

43.3M

Call Options Held

484K

Put Options Held

4.1K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.38B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account